Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice

Journal of Vascular Research

Volumn 40, Issue 2, 2003, Pages 87-96

  Villeneuve, Nicole ^a   Fortuno, Ana ^a   Sauvage, Marie ^a   Fournier, Nancy ^a   Breugnot, Christine ^a   Jacquemin, Christine ^a   Petit, Christine ^a   Gosgnach, Willy ^a   Carpentier, Nathalie ^a   Vanhoutte, Paul ^a   Vilaine, Jean Paul ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Atherosclerosis; Endothelial function; Mice; Nitric oxide; Nitric oxide synthase

Indexed keywords

APOLIPOPROTEIN E; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ISOENZYME; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BIOAVAILABILITY; DISEASE MODEL; ENZYME ANALYSIS; ENZYME LOCALIZATION; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPOPROTEIN DEFICIENCY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CATALASE; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERCHOLESTEROLEMIA; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 0038347442     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070705     Document Type: Article

References (35)

1. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-140.
2. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF: Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998;97:2494-2498.
3. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM: Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Tromb Vasc Biol 1997;17:2333-2340.
4. D'Uscio LV, Baker TA, Smith LA, Weiler D, Katusic ZS: Role of endothelial nitric oxide synthase in endothelial dysfunction of apolipo-protein E-deficient mice. Circulation 2000;102:281.
5. Yaghoubi M, Oliver-Krasinski J, Cayatte AJ, Cohen RA: Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 2000;36:751-757.
6. Laursen JB, Kurz S, Freeman BA, Tarpey MM, Harrison DG: Alterations of endothelium-dependent relaxation and vascular superoxide production in mice deficient in the ApoE gene. Circulation 1996;94(suppl 1):2703.
7. D'Uscio LV, Baker TA, Mantilla CB, Smith LA, Weiler D, Sieck GC, Katusic ZS: Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:1017-1022.
8. Iliou JP, Villeneuve N, Fournet-Bourguignon MP, Robin F, Jacquemin C, Lestriez V, Petit C, Pillon A, Vilaine JP: Mathematical treatment of chemiluminescence data allowing an optimised kinetic analysis of vascular NAD(P)H-dependent superoxide anion production. Analysis 2000;28:35-42.
9. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S: Evidence for induction of non-endothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharm 1993;21:841-845.
10. Behr D, Rupin A, Fabiani JN, Verbeuren TJ: Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 1999;142:335-344.
11. Boulanger CM, Heymes C, Benessiano J, Geske RS, Lévy BI, Vanhoutte PM: Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: Activation by angiotensin II in hypertension. Circ Res 1998;83:1271-1278.
12. Bradford M: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
13. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
14. Drexler H: Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 1999;43:572-579.
15. Luscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, CRC Press, 1990, pp 1-228.
16. Villeneuve N, Fortuno A, Sauvage M, Fournier N, Iliou JP, Breugnot C, Jacquemin C, Petit C, Briant C, Lestriez L, Vanhoutte PM, Vilaine JP: Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. J Vasc Res 2001;38:88.
17. Kauser K, DaCunha V, Fitch R, Mallari C, Rubanyi GM: Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 2000;278:H1679-H1685.
18. Adachi T, Cohen RA: Decreased aortic glutathione levels may contribute to impaired nitric oxide-induced relaxation in hypercholesterolemia. Br J Pharmacol 2000;129:1014-1020.
19. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N: Enhanced atherosclerosis and kidney dysfunction in eNOS -/- ApoE -/- mice are ameliorated by enalapril treatment. J Clin Invest 2000;105:451-458.
20. Jiang F, Gibson AP, Dusting GJ: Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: A comparison with apolipoprotein-E deficient mice. Eur J Pharmacol 2001;424:141-149.
21. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am J Physiol 1986;250:H822-H827.
22. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990;86:2109-2116.
23. Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, Hayashi Y, Itoh H, Yokoyama M: Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 1996;148:1949-1956.
24. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, Berk B: Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 1999;85:29-37.
25. Ramasamy S, Parthasarathy S, Harrison DG: Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J Lipid Res 1998;39:268-276.
26. Buttery L, Springdall D, Chester A, Evans T, Stanfield N, Parums D, Yacoub M, Polak J: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxinitrite. Lab Invest 1996;75:77-85.
27. Beckman JS, Ye YZ, Anderson PG: Extensive nitration of protein tyrosine in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994;375:81-88.
28. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey MM, Fukai T, Harrison DG: Endothelial regulation of vasomotion in ApoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001;103:1282-1288.
29. Féron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T: Endothelial nitric oxide synthase targeting to caveolae: Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996;271:22810-22814.
30. Féron O, Dessy C, Moniotte S, Desager JP, Balligand JL: Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 1999;103:897-905.
31. Darblade B, Caillaud D, Poirot M, Fouque MJ, Thiers JC, Rami J, Bayard F, Arnal JF: Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res 2001;50:566-576.
32. Fukai T, Galis ZS, Meng XP, Parthasarathy S, Harrison DG: Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest 1998;101:2101-2111.
33. Ma XL, Lopez BL, Liu GL, Christopher TA, Gao F, Guo Y, Feuerstein GZ, Ruffolo RR, Barone FC, Yue TL: Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury. Circ Res 1997;80:894-901.
34. Reardon CA, Getz GS: Mouse models of atherosclerosis. Curr Opin Lipidol 2001;167-173.
35. Geng YJ, Kil KS, Casscells SW: cDNA array analysis of gene expression in the aortas of apoliprotein-E deficient mice with atherosclerosis. Circulation 2000;102:197.